Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway
- PMID: 21897006
- DOI: 10.3233/JAD-2011-110884
Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway
Abstract
The sequential endoproteolytic cleavages operated by the γ-secretase and the β-secretase (BACE1) on the amyloid-β protein precursor (AβPP) result in the production of the amyloid-β (Aβ) species, with two C-terminal variants, at residue 40 or at residue 42. Accumulation in brain tissue of small, soluble aggregates of Aβ42 is the major pathogenic event of Alzheimer's disease (AD). However, the physiologic activity of Aβ peptides is still elusive. Here, we show that expression of BACE1 is regulated by Aβ42, which augments BACE1 gene transcription through the JNK/c-jun signaling pathway. Of note, Aβ40 has much less effect on BACE1 expression. These findings unveil a positive feedback loop in which γ-secretase cleavage of AβPP releases a functionally-active peptide, Aβ42, that promotes BACE1 transcription. Thus, gene expression induced by Aβ42 may have implications in the neuronal dysfunction and degeneration that occurs in AD.
Similar articles
-
Thiamine deficiency increases β-secretase activity and accumulation of β-amyloid peptides.Neurobiol Aging. 2011 Jan;32(1):42-53. doi: 10.1016/j.neurobiolaging.2009.01.005. Epub 2009 Feb 23. Neurobiol Aging. 2011. PMID: 19233513
-
Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.J Alzheimers Dis. 2010;22(2):469-82. doi: 10.3233/JAD-2010-100753. J Alzheimers Dis. 2010. PMID: 20847413
-
The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing.J Neurochem. 2011 Oct;119(1):231-9. doi: 10.1111/j.1471-4159.2011.07412.x. Epub 2011 Sep 1. J Neurochem. 2011. PMID: 21812781
-
The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.Biochem Soc Trans. 2007 Jun;35(Pt 3):574-6. doi: 10.1042/BST0350574. Biochem Soc Trans. 2007. PMID: 17511655 Review.
-
beta-Secretase, APP and Abeta in Alzheimer's disease.Subcell Biochem. 2005;38:79-103. Subcell Biochem. 2005. PMID: 15709474 Review.
Cited by
-
The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation.Front Cell Neurosci. 2023 Mar 6;17:1105247. doi: 10.3389/fncel.2023.1105247. eCollection 2023. Front Cell Neurosci. 2023. PMID: 36950516 Free PMC article. Review.
-
Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits.Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5225-30. doi: 10.1073/pnas.1422998112. Epub 2015 Apr 6. Proc Natl Acad Sci U S A. 2015. PMID: 25847999 Free PMC article.
-
Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities.Antioxid Redox Signal. 2019 Apr 10;30(11):1450-1499. doi: 10.1089/ars.2017.7321. Epub 2018 May 4. Antioxid Redox Signal. 2019. PMID: 29634350 Free PMC article. Review.
-
From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.Mol Neurobiol. 2012 Aug;46(1):186-93. doi: 10.1007/s12035-012-8307-4. Epub 2012 Jul 26. Mol Neurobiol. 2012. PMID: 22833458 Review.
-
Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer's Disease.Front Aging Neurosci. 2021 Mar 16;13:659402. doi: 10.3389/fnagi.2021.659402. eCollection 2021. Front Aging Neurosci. 2021. PMID: 33796019 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous